GENUSPLUS GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 AUD | +3.26% |
|
+0.80% | +35.71% |
| Apr. 15 | Euroz Hartleys Adjusts Genus Plus’ Price Target to AU$2.16 From AU$1.83, Keeps at Buy | MT |
| Apr. 15 | Genusplus Group Increases FY24 EBITDA Growth Guidance | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 61% by 2026.
- The stock, which is currently worth 2024 to 0.64 times its sales, is clearly overvalued in comparison with peers.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Construction & Engineering
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +35.71% | 223M | - | ||
| -2.51% | 68.13B | C+ | ||
| -0.79% | 57.68B | C+ | ||
| +18.78% | 37.52B | B+ | ||
| +11.43% | 30.83B | B | ||
| +3.63% | 27B | A- | ||
| +15.67% | 20.73B | B- | ||
| +15.36% | 19.52B | A | ||
| +68.84% | 17.1B | B | ||
| +22.41% | 16.98B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- GNP Stock
- Ratings GenusPlus Group Limited
